COPD: Management of The Frequent Exacerbator
|
|
- Opal Mills
- 5 years ago
- Views:
Transcription
1 SPRING 2013 Primary Care Asthma Program A number of primary care sites offering the Primary Care Asthma Program either have or are beginning to integrate COPD education as part of a broader Lung Health Program. In this edition, we feature an article by Dr. Denis O'Donnell from Queen's University, a world-renowned expert in COPD management as well as other COPD related topics that we hope you will find of interest COPD: Management of The Frequent Exacerbator The estimated prevalence of chronic obstructive pulmonary disease (COPD) in the general population is approximately 10%. It is predicted that COPD will become the third leading cause of death by In Canada, acute exacerbation of COPD (AECOPD) is the most common reason for admission to hospital Internal Medicine units and this has major economic implications. Exacerbation refers to a sudden and sustained worsening of the usual respiratory symptoms (dyspnea, cough and sputum) above the normal day-to-day variability, requiring an increase in usual medications or the use of additional medications. Currently, we have no biomarkers to confirm what is sometimes a rather tenuous diagnosis, based exclusively on clinical impression. The Importance of AECOPD Exacerbations, which are precipitated in the majority of patients by viral or bacterial infections, are important life events for patients with more Dr. Denis O Donnell, M.D., FRCP(I), FRCPC advanced COPD. AECOPD is associated with accelerated decline of lung function, increased activity restriction and reduced health-related quality of life. AECOPD requiring hospitalization is associated with increased short-term and long-term mortality, which incidentally, exceeds that of acute myocardial infarction. One of the most revolutionary developments in respiratory medicine in the past two decades has been refinements in non-invasive mechanical ventilation, which has reduced mortality in patients with AECOPD and acute respiratory failure by greater than 50%. While such patients are more likely to survive these lifethreatening events than ever before, they are at increased risk for future bouts of respiratory failure and require ongoing complex multi-disciplinary care.
2 The Frequent Exacerbator Phenotype Recent longitudinal studies in COPD populations have determined that some patients are more susceptible to recurrent AECOPDs (i.e. >2 per year) than others and that this susceptibility increases as the severity of airway obstruction increases. Patients with chronic bronchitis increased cough and sputum productivity for 3 consecutive months for 2 consecutive years appear to be more susceptible to recurrent AECOPD than those without. The single best predictor of future AECOPD is a previous AECOPD and can occur even in patients with moderate airway obstruction. Caregivers who encounter smokers who seek medical attention for repeated bouts of winter bronchitis must be vigilant that their patient may well be suffering from unrecognized exacerbations of COPD. This encounter presents an opportunity to confirm the diagnosis of COPD by arranging for elective spirometry and by initiating appropriate preventive measures. How Can We Effectively Prevent AECOPD? Our first task is to identify those patients with COPD who have a history of AECOPD, particularly those who have regular flare-ups (or lung attacks ) averaging 1-2 per year. Those who have previously required emergency visits or actual hospitalization for AECOPD merit special attention. All patients need to be instructed about the importance of early recognition and prompt treatment of AECOPD. The following are evidence- based recommendations for the prevention of AECOPD from the Canadian Thoracic Society. Effective treatment of AECOPD (characterized by muco-purulent sputum production) with first-order antibiotics and oral prednisolone (e.g mgs daily for 5-10 days) and intensified bronchodilator usage, should hasten recovery and delay the time to next AECOPD. For patients with advanced COPD, anti-microbial coverage against gram-negative organisms (e.g. the respiratory fluoroquinolones or amoxicillin-clavulanic acid) is generally recommended. For active smokers, every effort should be made to help them quit through regular counseling and pharmacotherapy when appropriate. Annual influenza vaccines are imperative and the pneumococcal vaccine (repeated once in 5-10 years) is indicated, as streptococcus pneumoniae remains one of the three main causes of bacterial AECOPD. Referral to a qualified COPD educator for initiation of a collaborative self-management plan, which has been shown to reduce hospitalizations and unscheduled office visits, is an important intervention. Basic instruction in proper inhaler technique is also a pivotal intervention which is often neglected. Action Plans the provision of a prescription for antibiotic and a short course of oral corticosteroid have been shown in selected patients to be effective (particularly if it is carefully supervised by a skilled health professional) in delaying the time to next AECOPD. Patients with moderate-to-severe COPD, who have a history of AECOPD, should receive a prescription for a long-acting anticholinergic bronchodilator and a combination long-acting beta-agonist/inhaled corticosteroid (i.e. triple therapy ), together with as needed short-acting bronchodilator. Ideally, patients with frequent AECOPD should be encouraged to engage in regular physical activity or, if possible, be enrolled in a supervised pulmonary rehabilitation program. Special Considerations Selected patients with COPD with recurrent AECOPD who have mucus- hypersecretion (chronic bronchitis) and moderate- to- severe airway obstruction, may benefit from prophylactic treatment with an oral antiinflammatory, phosphodiesterase-4 inhibitor (e.g. roflumilast 300 µg once daily) provided they can tolerate the gastrointestinal side effects. For selected patients with significant airway obstruction, who suffer recurrent exacerbations despite triple therapy, macrolide prophylaxis (e.g. azythromycin 500 mg p.o. three times weekly) may reduce the number of future AECOPD. Some patients with difficult to treat, recurrent AECOPD may require additional investigations to exclude the presence of bronchiectasis, recurrent aspiration or localized intra-luminal bronchial obstruction. Summary Exacerbations are important events in the lives of patients with COPD; they are known to increase morbidity and, in some instances, can be life-threatening. A careful history is needed to identify individuals who are at risk for recurrent exacerbations, so that they can be targeted for special attention and regular follow-up. Such individuals will benefit from structured education and participation in a collaborative self-management plan,
3 which will ensure the prompt recognition and treatment of AECOPD. Smoking cessation, annual vaccination and optimal foundational pharmacotherapy to maximize bronchodilation and reduce airway inflammation have all been shown to reduce the frequency and severity of AECOPD. Collectively, these measures together with rapid treatment of muco-purulent AECOPD, will improve associated morbidity and may actually prolong survival. Table 1: AECOPD Prevention Checklist Smoking cessation Vaccinations Self-management education with Case Manager and written Action Plan (antibiotic, oral corticosteroids) Regular triple therapy (LAMA + ICS/LABA) Pulmonary rehabilitation, activity promotion Consider PDE4 inhibitors or macrolide prophylaxis Abbreviations: LAMA, long-acting muscarinic antagonist; ICS, inhaled corticosteroid; LABA, long-acting beta2-agonist; PDE4, phosphodiesterase-4. References 1. O Donnell DE, Aaron S, Bourbeau J, Hernandez P, Marciniuk DD, Balter M, Ford G, Gervais A, Goldstein R, Hodder R, Kaplan A, Keenan S, Lacasse Y, Maltais F, Road J, Rocker G, Sin D, Sinuff T, Voduc N. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease 2007 update. Can Respir J 2007; 14(Suppl B): 5B-32B. 2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease revised Rennard SI, Calverley PM, Goehring UM, Bredenbroker D, Martinez JF. Reduction of exacerbations by the PDE4 inhibitor roflumilast the importance of defining different subsets of patients with COPD. Respir Res 2011; 12: Albert RK, Connett J, Bailey WC; for the COPD Clinical Research Network. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 2011; 365: PCAP Welcomes New Provincial Coordinator: Sara Han According to the World Health Organization (WHO), lung disease will soon be the third leading cause of death in the world. Today, more than 2.4 million people in Ontario are living with serious lung disease and this number is expected to grow by 50 percent in the next 30 years. The Primary Care Asthma Program (PCAP), part of the Asthma Plan of Action, has just celebrated its 10 year anniversary. PCAP has shown evidence of decreasing ER visits for asthma by 50% and decreasing asthma attacks by 30% by implementing best practice for asthma in the primary care setting. I am excited to join this group to continue to promote best practice in chronic respiratory disease management in primary care for the future. Sara Han, RRT, CRE, B.Sc. PCAP Provincial Coordinator Ontario Lung Association I am a Registered Respiratory Therapist and coming from a hospital/acute care background, I have been in the frontline of exacerbations. I have always wanted to support the patient before they walked into the emergency room department to prevent them from going there in the first place. I followed this passion to obtain my certification in respiratory education (CRE) and have worked as a respiratory educator in various primary care settings (solo physician s offices and Family Health Teams). This has led me to where I am today, the new PCAP Provincial Coordinator at the Ontario Lung Association. Although I am not in direct contact with the patient anymore, I have a satisfaction in knowing that my role in implementing an evidence-based program throughout primary care in Ontario, will ultimately provide best practice standards to the patient. I envision PCAP to expand its standards throughout Ontario and be a leader in chronic respiratory disease care, aligned with the Ministry of Health and Long Term Care s health strategies to provide the best care for people suffering from respiratory disease in Ontario. I am excited for the next years to come for PCAP as we find ways to innovate and use technology to support PCAP to promote healthier lungs in Ontario.
4 SARA Dear Sara, The FHT I work in has decided to provide a respiratory health education program. I have heard about CAE and CRE designations. What is the difference and how do I go about becoming certified? That is great! The cornerstones of a good respiratory health education program are credible and knowledgeable providers and the Canadian Network for Respiratory Care (CNRC) helps to ensure this through national certification and designation. In order to be eligible to write the Certified Asthma Educator (CAE) or the Certified Respiratory Educator (CRE) exam, you must have a degree or diploma in a recognized health care profession, your scope of practice must include counseling clients, you must have completed a CNRC approved education program, and you must pay the required sitting fee for the exam. In regards to the CNRC approved education program requirement; if you would like to challenge the CAE exam, you must have successfully completed a CNRC approved asthma educator education program. If you would like to challenge the CRE exam, you must have successfully completed both a CNRC approved asthma educator program and a COPD educator education program or a CNRC approved respiratory educator program. Please see for more information and for a list of CNRC approved educator programs. at shan@on.lung.ca
5 Asthma and COPD Education: Much the Same But Different Asthma and COPD are very similar but also very different disease processes that educators need to remember. There is an overlap in the clinical features of both diseases, but we must remember that these are two distinct conditions and often care of a person with COPD is much more complex. Once our patients who have asthma have achieved good control of their disease, we know that they can go through most days doing the things they want to do and need to do with little impact from their asthma. However, with COPD airway obstruction is not fully reversible, so symptoms are usually fairly constant and progressive. Pamela Wilton, RN, CRE Although, our COPD population includes younger women than it did years ago, it is rare to be diagnosed in young adults. Once past the age of 55 years, the chance of having one or more chronic diseases increases every year for Canadians. It means that we must help patients with COPD manage with co-existing disease such as arthritis, diabetes, cardiac disease, hypertension and cancer. Depression and anxiety, common in people with chronic disease, need special attention to manage. It is essential to have an interdisciplinary approach to COPD management. Principles of adult education do not change, but our strategies and tools may need to change in COPD to accommodate those who may have more problems with hearing and/or vision. Cognitive problems present further challenges. On a positive note, often (not always) patients with COPD are no longer working and have more flexibility in terms of their time. They are often very well motivated to learn how to better manage their disease as they want a better quality of life. Greater access to information helps many to be better informed about their own health, standards of care, community resources and choices of therapy. Educators can provide assistance to navigate the health care system, helping patients to know when and how to seek care appropriately. We must remember that frequently our patients with COPD are the sole caregiver for a spouse or other family member, in their home, who has even more health problems. Fixed incomes, transportation difficulties and limited support systems may become barriers to education. We must be alert to this and work to facilitate access to education and follow-up that makes sense for each patient. Getting to better understand and know about their socio-economic situation and working to assist them, as appropriate, can increase their ability to learn and better manage their own health. Fortunately, PCAP encourages follow-up. Follow-up gives educators a chance to evaluate changes, to enhance skill development, to adjust care plans, and to understand how well patients have been able to utilize what they have learned to reach their goals. More importantly, it gives patients and educators a chance to develop a rapport, working together to enhance knowledge and skills to achieve better health outcomes. So remember, while there are many similarities in asthma and COPD, there are important differences that educators need to think about and be prepared to adjust to meet the needs of both groups of patients. Fortunately, educators know how to do it and for those who are new to caring for individuals with COPD it will just take time and practice.
6 Community COPD Rehabilitation Program Somerset West Community Health Centre The Lung Health program, at Somerset West Community Health Centre (CHC), provides COPD care for a network of seven Community Health Centres and one Aboriginal Health Centre. The population served is over 80,000 people. If we consider that currently 4% of the Canadian population is diagnosed with COPD, there are approximately 3,200 people in our catchment areas diagnosed with COPD who could benefit from Pulmonary Rehabilitation (PR). The capacity of the Lung Health program, with current funding, is 250 unique clients per year. There are 36 PR client spots available per year, therefore; approximately 15% of clients who are followed by the Lung Health program can attend PR. This is better than the national average of 2%. Better, but still not great. A recent national report card issued by the Canadian Lung Association identified that most provinces could do better. Exercise is the predominant modality including muscle strengthening, endurance training (cycling or treadmill), breathing exercises, training for activities of daily living, energy conservation and a home exercise prescription. What is different about this program? Twenty-eight percent of the clients attending PR are still smoking. Clients may begin PR while using a reduction strategy to quit smoking. They are offered free nicotine replacement therapy through the STOP with CHC CAMH study. Experience shows that change is facilitated by supporting quit attempts, as clients begin to make change in lifestyle by exercising regularly. Regular exercise and physical activity are The Lung Health program at Somerset West CHC vital to clients physical and emotion health. COPD clients gain confidence in their ability to exercise and are supported to get started on a more active way of life. Community Health Centre Somerset West Community Health Centre 55 Eccles Street Ottawa, Ontario SWCHC Satellite Location 30 Rosemount Avenue Ottawa, Ontario
7 Ontario is improving care for seniors and others with complex conditions through Health Links. This innovative approach brings together health care providers in a community to better and more quickly coordinate care for high-needs patients. How will Health Links benefit patients? When different health care providers work as a team to care for a patient, they can better coordinate the full patient journey through the health system, leading to better care for patients. Health Links will help to ensure that patients with complex conditions: No longer need to answer the same question from different providers. Have support to ensure they are taking the right medications appropriately. Have a care provider they can call, eliminating unnecessary provider visits. Have an individualized comprehensive plan, developed with the patient and his/her care providers who will ensure the plan is being followed. How will Health Links work? Networks in Ontario Health Links will encourage greater collaboration between existing local health care providers, including family care providers, specialists, hospitals, long-term care, home care and other community supports. With improved coordination and information sharing, patients will receive faster care, will spend less time waiting for services and will be supported by a team of health care providers at all levels of the health care system. Health Links put family care providers at the centre of the health care system. By bringing local health care providers together as a team, Health Links will help family doctors to connect patients more quickly with specialists, home care services and other community supports, including mental health services. For patients being discharged from hospital, the Health Link will allow for faster follow-up and referral to services like home care, helping reduce the likelihood of re-admission to hospital. The 23 Health Links Networks that are currently implemented: 1. Erie St. Clair LHIN Chatham City Centre Health Link Coordinator: Chatham Kent Health Alliance 3. WATERLOO WELLINGTON LHIN Guelph Health Link Coordinator: Guelph Family Health Team 5. CENTRAL WEST LHIN North Etobicoke-Malton Health Link Coordinator: Central West Community Care Access Centre Dufferin Health Link Coordinator: Headwaters Health Care Centre 2. SOUTH WEST LHIN Perth County Health Link Coordinator: North Perth Family Health Team 4. HAMILTON NIAGARA HALDIMAND BRANT LHIN Hamilton Central Health Link Coordinator: McMaster Family Health Team 6. MISSISSAUGA HALTON LHIN South East Mississauga & West Toronto Health Link Coordinator: Summerville Family Health Team
8 7. TORONTO CENTRAL LHIN Don Valley/Greenwood Health Link Coordinator: WoodGreen Community Services East Toronto Health Link Coordinator: South East Toronto Family Health Team Mid-Toronto West Health Link Coordinator: Taddle Creek Family Health Team Partners include: o University Health Network (Toronto General, Toronto Western, Princess Margaret, Toronto Rehab) o Toronto Central CCAC o Women's College Hospital o CAMH (Queen Street, The Clarke, ARF) o Primary care providers: Toronto Western FHT, Women's College FHT, Mount Sinai FHT o Access Alliance Community Health Centre o Central Toronto Community Health Centre o Toronto Public Health o Anishnawbe Health Toronto o Centre Francophone de Toronto o And other community support services North Toronto East Health Link Coordinator: Sunnybrook Hospital 10. SOUTH EAST LHIN Kingston Health Link Coordinator: Maple Family Health Team Quinte Health Link Coordinator: Belleville and Quinte West Community Health Centre Rural Hastings Health Link Coordinator: Gateway Community Health Centre Rural Kingston Health Link Coordinator: Rural Kingston Family Health Organization Thousand Island Health Link Coordinator: Upper Canada Family Health Team 8. CENTRAL LHIN South Simcoe and Northern York Region Health Link Coordinator: Southlake Regional Health Centre North York Region Health Link Coordinator: North York General Hospital 9. CENTRAL EAST LHIN Peterborough Health Link Coordinator: Central East Community Care Access Centre 12. NORTH SIMCOE MUSKOKA LHIN Barrie Community Health Link Coordinator: Barrie Family Health Team South Georgian Bay Health Link Coordinator: South Georgian Bay Community Health Centre 13. NORTH EAST LHIN Temiskaming Health Link Coordinator: Le Centre de santé communautaire de Temiskaming Timmins Health Link Coordinator: Timmins Family health Team Submitted by Nancy Garvey (Senior Program Consultant at Ontario Ministry of Health and Long-Term Care) and reproduced with permission from the Ministry of Health and Long-Term Care. (Ministry of Health and Long-Term Care news releases December 6, 2012: About Health Links) and Ontario Health Links
9 Provider Education Program (PEP) Workshops June 26, 2013 Adult Asthma in Hamilton registration here: Dr. Chris Allen Presenting September 11, 2013 Spirometry Interpretation Renfrew/Pembroke venue to be confirmed stay tuned to for more information September 18th, 2013 Spirometry Interpretation in Hamilton at the Royal Hamilton Yacht Club 5:30 8:30pm registration available soon. September 25, 2013 Spirometry Interpretation North Bay venue to be confirmed stay tuned to for more information
COPD Treatable. Preventable.
My COPD Action Plan Patient s Copy (Patient s Name) Date Canadian Respiratory COPD Treatable. Preventable. This is to tell me how I will take care of myself when I have a COPD flare-up. My goals are My
More information2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters
GOLD Objectives To provide a non biased review of the current evidence for the assessment, diagnosis and treatment of patients with COPD. To highlight short term and long term treatment objectives organized
More informationTHE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable
THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc. COPD in the United States Third leading cause
More informationBeyond the Next Breath: Controlling Costs and Maximizing COPD Outcomes
Beyond the Next Breath: Controlling Costs and Maximizing COPD Outcomes Edith Haage, PT, GCS NewCourtland Senior Services 10/21/2015 NEWCOURTLAND.org 1-888-530-4913 http://www.poliosurvivorsnetwork.org.uk/archive/lincolnshire/library/australia/paleop/ima
More informationHow to treat COPD? What is the mechanism of dyspnea? Smoking cessation
: The Increasing Role of the FP Alan Kaplan, MD, CCFP(EM) Presented at the Primary Care Today: Education Conference and Medical Exposition, Toronto, Ontario, May 2006. Chronic obstructive pulmonary disease
More informationGuideline for the Diagnosis and Management of COPD
Guideline for the Diagnosis and Management of COPD Introduction Chronic obstructive pulmonary disease (COPD) is a respiratory disorder largely caused by smoking. It is characterized by progressive, partially
More informationProvincial Sarcoma Services Plan VERSION 2.0 DECEMBER 2015
Provincial Sarcoma Services Plan 1 VERSION 2.0 DECEMBER 2015 PROVINCIAL SARCOMA SERVICES PLAN Contents What is the Provincial Sarcoma Services Plan? 3 The Rationale for Organizing Sarcoma Services The
More informationMoving from pa-ent to popula-on and community- based management
Moving from pa-ent to popula-on and community- based management Ways and Means: Health Links 2015 Walter P Wodchis Health System Performance Research Network February 26, 2015 3 SuggesDons 1. ConDnue to
More informationManagement of Acute Exacerbations of COPD
MiCMRC Educational Webinar Management of Acute Exacerbations of COPD August 22, 2018 MiCMRC Educational Webinar Management of Acute Exacerbations of COPD Expert Presenter: Catherine A. Meldrum PhD RN MS
More informationChronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD) Scope: The guideline provides strategies for the improved diagnosis and management of adults with chronic bronchitis and emphysema (chronic obstructive pulmonary
More informationNational COPD Audit Programme
National COPD Audit Programme Planning for every breath National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme: Primary care audit () 2015 17 Data analysis and methodology Section 4: Providing
More informationCOPD: Preventable and Treatable. Lecture Outline. Diagnosis of COPD. COPD: Defining Terms
COPD: Preventable and Treatable Christopher H. Fanta, M.D. Partners Asthma Center Pulmonary and Critical Care Division Brigham and Women s Hospital Harvard Medical School Lecture Outline I. Diagnosis and
More informationTurning Science into Real Life Roflumilast in Clinical Practice. Roland Buhl Pulmonary Department Mainz University Hospital
Turning Science into Real Life Roflumilast in Clinical Practice Roland Buhl Pulmonary Department Mainz University Hospital Therapy at each stage of COPD I: Mild II: Moderate III: Severe IV: Very severe
More informationAECOPD: Management and Prevention
Neil MacIntyre MD Duke University Medical Center Durham NC Professor P.J. Barnes, MD, National Heart and Lung Institute, London UK Professor Peter J. Barnes, MD National Heart and Lung Institute, London
More informationAdvances in the management of chronic obstructive lung diseases (COPD) David CL Lam Department of Medicine University of Hong Kong October, 2015
Advances in the management of chronic obstructive lung diseases (COPD) David CL Lam Department of Medicine University of Hong Kong October, 2015 Chronic obstructive pulmonary disease (COPD) COPD in Hong
More informationLead team presentation: Roflumilast for treating chronic obstructive pulmonary disease [ID984]
Lead team presentation: Roflumilast for treating chronic obstructive pulmonary disease [ID984] 1 st Appraisal Committee meeting Background & Clinical Effectiveness John McMurray 11 th January 2016 For
More informationChronic obstructive pulmonary disease
0 Chronic obstructive pulmonary disease Implementing NICE guidance June 2010 NICE clinical guideline 101 What this presentation covers Background Scope Key priorities for implementation Discussion Find
More informationCentral LHIN Health Service Needs Assessment and Gap Analysis:
Central LHIN Health Service Needs Assessment and Gap Analysis: Appendix I: Cardiology & Cardiovascular Analysis November 2008 Final Interim Report 1 Cardiology & Cardiovascular: Summary of Gaps Although
More informationChronic Obstructive Pulmonary Disease (COPD) Clinical Guideline
Chronic Obstructive Pulmonary Disease (COPD) Clinical These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They
More informationA Plan for Parkinson s in Ontario:
A Plan for Parkinson s in Ontario: Parkinson s is a complex disease that impacts every area of a person s life. Simple solutions can create significant changes for Ontarians by improving health outcomes
More informationSurveillance report Published: 6 April 2016 nice.org.uk. NICE All rights reserved.
Surveillance report 2016 Chronic obstructive pulmonary disease in over 16s: diagnosis and management (2010) NICE guideline CG101 Surveillance report Published: 6 April 2016 nice.org.uk NICE 2016. All rights
More informationList of Exhibits Adult Stroke
List of Exhibits Adult Stroke List of Exhibits Adult Stroke i. Ontario Stroke Audit Hospital and Patient Characteristics Exhibit i. Hospital characteristics from the Ontario Stroke Audit, 200/ Exhibit
More informationPrince Edward Island Chronic Obstructive Pulmonary Disease (COPD) Trends
Prince Edward Island Chronic Obstructive Pulmonary Disease (COPD) Trends 2001-2011 December 2014 Population Health Assessment and Surveillance Unit, Chief Public Health Office, Department of Health and
More informationWhat s New in Acute COPD? Dr Nick Scriven Consultant AIM President SAM
What s New in Acute COPD? Dr Nick Scriven Consultant AIM President SAM Covering: Basic Definition New assessment criteria Some newer treatments BiPAP Not Covering: Definitions: Chronic Obstructive Pulmonary
More informationPharmacotherapy for COPD
10/3/2017 Topics to be covered Pharmacotherapy for chronic treatment Pharmacotherapy for COPD Dr. W C Yu 3rd September 2017 Commonly used drugs Guidelines for their use Inhaled corticosteroids (ICS) in
More informationCOPD: From Hospital to Home October 5, 2015 Derek Linderman, MD Associate Professor COPD Center Pulmonary Nodule Clinic
COPD: From Hospital to Home October 5, 2015 Derek Linderman, MD Associate Professor COPD Center Pulmonary Nodule Clinic Learning Objectives Know the adverse effects of COPD exacerbations Know mainstays
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary and secondary
More informationCommissioning for Better Outcomes in COPD
Commissioning for Better Outcomes in COPD Dr Matt Kearney Primary Care & Public Health Advisor Respiratory Programme, Department of Health General Practitioner, Runcorn November 2011 What are the Commissioning
More informationCARE OF THE ADULT COPD PATIENT
CARE OF THE ADULT COPD PATIENT Target Audience: The target audience for this clinical guideline is all MultiCare providers and staff including those associated with our Clinically Integrated Network. The
More informationJOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES
JOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES Authors Dr Ian Benton Respiratory Consultant COCH Penny Rideal Respiratory Nurse COCH Kirti Burgul Respiratory Pharmacist COCH Pam
More informationPROVINCIAL LEAD AND LHIN LEADER BIOS
PROVINCIAL LEAD AND LHIN LEADER BIOS May 4, 2006 Dr. Bernard Lawless, Provincial Lead Dr. Bernard Lawless completed a residency in general surgery at the University of Western Ontario (UWO) and then did
More informationHQO s Episode of Care for Chronic Obstructive Pulmonary Disease
HQO s Episode of Care for Chronic Obstructive Pulmonary Disease Dr. Chaim Bell, MD PhD FRCPC Ontario Hospital Association Webcast October 23, 2013 Objectives 1. Describe the rationale and methodology for
More informationCancer Risk Factors in Ontario. Youth
Cancer Risk Factors in Ontario Youth 3. Youth 3.1 Current smoking Figure 18. Trends in current smoking prevalence among Ontario teens (aged 12 19), by sex, 3 11 Males Females 4 3 4 5 6 7 8 9 11 Year Notes:
More informationCOPD Update. Muhammad Talha Khan MD. COPD Exacerbations. COPD Clinical Importance. COPD Pathophysiology. Overview/Objectives
Overview/Objectives COPD Update Muhammad Talha Khan MD Pulmonologist St Croix Regional Medical Center, St Croix Falls, WI. Overview of COPD and disease impact Classification of COPD Severity Treatment
More informationCOPD: Current Medical Therapy
COPD: Current Medical Therapy Angela Golden, DNP, FNP-C, FAANP Owner, NP from Home, LLC Outcomes As a result of this activity, learners will be able to: 1. List the appropriate classes of medications for
More informationOverview LHIN 4 10/4/2014. Diagnostic Assessment Programs for Lung & Esophageal Cancer. Improving the Patient Experience.
Diagnostic Assessment Programs for Lung & Esophageal Cancer Improving the Patient Experience CSGNA 2014 DR. COLIN SCHIEMAN ASSOCIATE PROFESSOR THORACIC SURGERY MCMASTER UNIVERSITY Overview Introduction
More informationCOPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis.
1 Definition of COPD: COPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis. Airflow obstruction may be accompanied by airway hyper-responsiveness
More informationOntario Wait Time Strategy
Ontario Wait Time Strategy Visit to South East LHIN May 26, 2008 Alan R. Hudson, OC, FRCSC Cataract Surgery 90 th Percentile Wait Time Trend 350 300 250 200 Priority 4 Target - 182 days 150 100 50 0 2
More informationCOPD: A Renewed Focus. Disclosures
COPD: A Renewed Focus Heath Latham, MD Assistant Professor Division of Pulmonary and Critical Care Medicine Disclosures No Business Interests No Consulting No Speakers Bureau No Off Label Use to Discuss
More informationGlobal Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline. MedStar Health
Global Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline MedStar Health These guidelines are provided to assist physicians and other clinicians in making decisions
More informationDisclosure and Conflict of Interest 8/15/2017. Pharmacist Objectives. At the conclusion of this program, the pharmacist will be able to:
Digging for GOLD Rebecca Young, PharmD, BCACP, Roosevelt University College of Pharmacy Assistant Professor of Clinical Sciences Practice Site Advocate Medical Group-Nesset Pavilion Disclosure and Conflict
More informationInformation and Data Brief: Hip Fracture
Information and Data Brief: Hip Fracture Care for People With Fragility Fractures Find out why a particular quality standard was created and the data behind it Quality Standards are: Concise sets of easy-to-understand
More informationCOPD: Applying New Guidelines to Optimizing Evaluation and Treatment
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationImproving access to pulmonary rehabilitation through Medicare Benefit Scheme subsidies
Improving access to pulmonary rehabilitation through Medicare Benefit Scheme subsidies FREQUENTLY ASKED QUESTIONS Contents: About Lung Foundation Australia s Medicare Benefit Scheme Application Page 1
More informationLEARNING OBJECTIVES FOR COPD EDUCATORS
LEARNING OBJECTIVES FOR COPD EDUCATORS For further Information contact: INTERNATIONAL NETWORK FOR RESPIRATORY CARE 16851 Mount Wolfe Road Caledon, ON Canada L7E 3P6 Phone: 905 880-1092 Fax: 905 880-9733
More informationWhat s new in COPD? Apichart Khanichap MD. Department of Medicine, Faculty of Medicine, Thammasat university
What s new in COPD? Apichart Khanichap MD. Department of Medicine, Faculty of Medicine, Thammasat university Management stable COPD Relieve symptoms Improve exercise tolerance Improve health status Prevent
More informationASTHMA CARE FOR CHILDREN BASKET OF CARE SUBCOMMITTEE Report to: Minnesota Department of Health. June 22, 2009
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp ASTHMA CARE FOR CHILDREN
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
DRAFT NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary
More informationSABA: VENTOLIN EVOHALER (SALBUTAMOL) SAMA: ATROVENT IPRATROPIUM. Offer LAMA (discontinue SAMA) OR LABA
COPD GUIDELINES DIAGNOSIS >35 years of age Symptoms of cough, breathlessness, sputum, wheeze, Risk factor (SMOKING) Spirometry (post bronchodilator) FEV1/FVC = 0.7 ENCOURAGE PATIENTS TO BRING INHALERS
More informationCLINICAL PATHWAY. Acute Medicine. Chronic Obstructive Pulmonary Disease
CLINICAL PATHWAY Acute Medicine Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Table of Contents (tap to jump to page) INTRODUCTION 1 Scope of this Pathway 1 Pathway Contacts
More informationChronic Obstructive Pulmonary Disease (COPD) KAREN ALLEN MD PULMONARY & CRITICAL CARE MEDICINE VA HOSPITAL OKC / OUHSC
Chronic Obstructive Pulmonary Disease (COPD) KAREN ALLEN MD PULMONARY & CRITICAL CARE MEDICINE VA HOSPITAL OKC / OUHSC I have no financial disclosures Definition COPD is a preventable and treatable disease
More informationMedical Assistance in Dying Community of Practice January 12, 2018
Medical Assistance in Dying Community of Practice January 12, 2018 1 Discussion forum to support : MAID Community of Practice (CoP) Webinars Awareness of resources to enable HCP to meet their professional
More informationChronic Obstructive Pulmonary Disease (COPD) Treatment Guidelines
Chronic Obstructive Pulmonary Disease (COPD) Treatment Guidelines Where appropriate the following should be offered before commencing inhaled treatment: Offer treatment and support to stop smoking. Smoking
More informationCOPD. Breathing Made Easier
COPD Breathing Made Easier Catherine E. Cooke, PharmD, BCPS, PAHM Independent Consultant, PosiHleath Clinical Associate Professor, University of Maryland School of Pharmacy This program has been brought
More informationHips & Knees Priority Action Team
Hips & Knees Priority Action Team Current State Data Refresh September 5, 27 Overview Population Profile Health Status Utilization of Hip & Knee Total Joint Services 1 1 Population Profile 2 SouthWest
More informationTreatment. Assessing the outcome of interventions Traditionally, the effects of interventions have been assessed by measuring changes in the FEV 1
58 COPD 59 The treatment of COPD includes drug therapy, surgery, exercise and counselling/psychological support. When managing COPD patients, it is particularly important to evaluate the social and family
More informationBridges to Excellence Chronic Obstructive Pulmonary Disease Care Recognition Program Guide
Bridges to Excellence Chronic Obstructive Pulmonary Disease Care Recognition Program Guide Altarum Bridges to Excellence 3520 Green Court, Suite 300 Ann Arbor, MI 48105 bte@altarum.org www.bridgestoexcellence.org
More informationCOPD in primary care: reminder and update
COPD in primary care: reminder and update Managing COPD continues to be a major feature of primary care, particularly in practices with a high proportion of M ori and Pacific peoples. COPDX clinical practice
More informationInformation and Data Brief: Venous Leg Ulcers. Find out why a particular quality standard was created and the data behind it
Information and Data Brief: Venous Leg Ulcers Find out why a particular quality standard was created and the data behind it Quality Standards are: Concise sets of easy-to-understand statements outlining
More informationReference Guide for Group Education
A p l a n o f a c t i o n f o r l i f e Reference Guide for Group Education Session 5 Plan of Action: Part I Overview of the Plan of Action and Management of Respiratory Infections Plan of Action: Objectives
More informationThe Ontario Hepatitis C Multidisciplinary Team Model. Samantha Earl, RN, Senior Policy Analyst 2013 CATIE Forum Wednesday September 18, 2013
The Ontario Hepatitis C Multidisciplinary Team Model Samantha Earl, RN, Senior Policy Analyst 2013 CATIE Forum Wednesday September 18, 2013 History The Ontario Hepatitis Nursing Program was announced by
More informationCOPD. Helen Suen & Lexi Smith
COPD Helen Suen & Lexi Smith What is COPD? Chronic obstructive pulmonary disease: a non reversible, long term lung disease Characterized by progressively limited airflow and an inability to perform full
More informationOPTIMIZING MANAGEMENT OF COPD IN THE PRACTICE SETTING 10/16/2018 DISCLOSURES I have no financial or other disclosures
OPTIMIZING MANAGEMENT OF COPD IN THE PRACTICE SETTING J. Michael Fuller, MD, MEd, FACP, FCCP Associate Professor of Medicine University of South Carolina Greenville DISCLOSURES I have no financial or other
More informationASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?
ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss? Randall W. Brown, MD MPH AE-C Association of Asthma Educators Annual Conference July 20, 2018 Phoenix, Arizona FACULTY/DISCLOSURES Randall Brown,
More informationCollaborative & Introduction to the SHRTN Library Service. SHRTN founded in 2005 Funded in part by the Ontario Ministry of Health and Long Term Care
Overview of the SHRTN Collaborative & Introduction to the SHRTN Library Service SHRTN founded in 2005 Funded in part by the Ontario Ministry of Health and Long Term Care SHRTN Collaborative SHRTN Collaborative
More informationDirectional Plan Vision Care Strategy. Central East LHIN Board of Directors December 17, 2014
Directional Plan Vision Care Strategy Central East LHIN Board of Directors December 17, 2014 Agenda Project Overview Key Current State Findings Recommendations What it Means for Central East LHIN Next
More informationIntegrated Cardiopulmonary Pharmacology Third Edition
Integrated Cardiopulmonary Pharmacology Third Edition Chapter 13 Pharmacologic Management of Asthma, Chronic Bronchitis, and Emphysema Multimedia Directory Slide 7 Slide 12 Slide 60 COPD Video Passive
More informationChronic Obstructive Pulmonary Disease (COPD) Measures Document
Chronic Obstructive Pulmonary Disease (COPD) Measures Document COPD Version: 3 - covering patients discharged between 01/10/2017 and present. Programme Lead: Jo Higgins Clinical Lead: Dr Paul Albert Number
More informationCOPD. The goals of COPD. about. you quit. If you. efforts to quit. Heart
How Is COPD Treated? COPD has no cure yet. However, lifestyle changes and treatments can help you feel better, stay more active, and slow the progress of the disease. The goals of COPD treatment include:
More informationTEACH: Training practitioners in smoking cessation counselling
TEACH: Training practitioners in smoking cessation counselling Treatments to help people quit smoking are among the most cost-effective ways to reduce the risk of disease or death. The likelihood of quitting
More informationUpdate on Pulmonary Rehabilitation Programme. HA Convention Dr. Wong WY, Ida Haven of Hope Hospital 8 May 2018
Update on Pulmonary Rehabilitation Programme HA Convention Dr. Wong WY, Ida Haven of Hope Hospital 8 May 2018 Impacts of COPD to patients Increase dyspnoea Limitation of activity Decrease quality of life
More information2012 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members
2012 Chronic Respiratory Program Evaluation Our mission is to improve the health and quality of life of our members 2012 Chronic Respiratory Program Evaluation Program Title: Chronic Respiratory Program
More information2017 GOLD Report. Is it worth its weight in GOLD??? CSHP-NB Fall Education Day September 30, 2017
2017 GOLD Report Is it worth its weight in GOLD??? CSHP-NB Fall Education Day September 30, 2017 Lauren Munro; BSc(Pharm) Amanda Burns; BSc(Pharm) Pharmacy Residents The Moncton Hospital Objectives Explain
More informationCOPD GOLD Guidelines & Barnet inhaler choices. Dr Dean Creer, Respiratory Consultant, Royal Free London NHS Foundation Trust
COPD GOLD Guidelines & Barnet inhaler choices Dr Dean Creer, Respiratory Consultant, Royal Free London NHS Foundation Trust GOLD 2017 Report: Chapters 1. Definition and Overview 2. Diagnosis and Initial
More information2017 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members
2017 Chronic Respiratory Program Evaluation Our mission is to improve the health and quality of life of our members 2017 Chronic Respiratory Program Evaluation Program Title: Chronic Respiratory Program
More informationAmerican Thoracic Society (ATS) Perspective
National Surveillance System for Chronic Lung Disease (CLD): American Thoracic Society (ATS) Perspective Gerard J. Criner, M.D. Chronic Obstructive Pulmonary Disease (COPD) l Definition: Group of chronic
More informationCOPD, Asthma, Or Something In Between? Sharon R. Rosenberg Assistant Professor of Medicine Northwestern University December 4, 2013
COPD, Asthma, Or Something In Between? Sharon R. Rosenberg Assistant Professor of Medicine Northwestern University December 4, 2013 None Disclosures Definitions Asthma Asthma is a chronic inflammatory
More informationOptimum COPD Care in 2010 Why Not Now? David E. Taylor, M.D. Pulmonary/Critical Care Ochnser Medical Center
Optimum COPD Care in 2010 Why Not Now? David E. Taylor, M.D. Pulmonary/Critical Care Ochnser Medical Center dtaylor@ochsner.org Observations from Yesterday EPIC is epidemic No EMR No Way!!! Accountability/Benchmarking
More informationDementia Evidence Brief:
Dementia Evidence Brief: North Simcoe Muskoka Local Health Integration Network, July 2012 20 Eglington Avenue, 16th Floor, Toronto, Ontario M4R 1K8 T 416-967-5900 F 416-967-3826 E staff@alzheimeront.org
More informationAdvances in Chronic Obstructive Pulmonary Disease
Advances in Chronic Obstructive Pulmonary Disease By Dave C. Todd, MD; and Darcy D. Marciniuk, MD, FRCPC The case of Nina Nina, 64, presents to the clinic with a three- to fouryear history of progressive,
More informationOHTAC Recommendation: Chronic Obstructive Pulmonary Disease (COPD) Ontario Health Technology Advisory Committee
OHTAC Recommendation: Chronic Obstructive Pulmonary Disease (COPD) Ontario Health Technology Advisory Committee March 2012 Background The Chronic Obstructive Pulmonary Disease Mega-Analysis series is made
More informationAnyone who smokes and/or has shortness of breath and sputum production could have COPD
COPD DIAGNOSIS AND MANAGEMENT CHECKLIST Anyone who smokes and/or has shortness of breath and sputum production could have COPD Confirm Diagnosis Presence and history of symptoms: Shortness of breath Cough
More information$1.4 Million Allocated to Cardiac Rehabilitation Services!
$1.4 Million Allocated to Cardiac Rehabilitation Services! Cardiac Rehabilitation in New Brunswick- A Province on the Move! Background The incidence of cardiovascular disease (CVD) in New Brunswick (NB)
More informationDementia Evidence Brief: Ontario
Dementia Evidence Brief: Ontario August 2012 20 Eglinton Avenue West, 16th Floor, Toronto, Ontario M4R 1K8 T 416-967-5900 F 416-967-3826 E staff@alzheimeront.org www.alzheimer.ca/on Dementia Evidence Brief:
More informationDesign - Multicentre prospective cohort study. Setting UK Community Pharmacies within one CCG area within the UK
Enabling Patient Health Improvements through COPD (EPIC) Medicines Optimisation within Community Pharmacy: a prospective cohort study Abstract Objectives To improve patients ability to manage their own
More informationEffective routine electronic symptom screening and use of evidence-informed guides to support symptom management in Ontario, Canada
Effective routine electronic symptom screening and use of evidence-informed guides to support symptom management in Ontario, Canada August 28, 2012 Esther Green, Provincial Head, Nursing & PSO, Cancer
More informationReference Guide for Group Education
A p l a n o f a c t i o n f o r l i f e Reference Guide for Group Education Session 1 Introduction to Living Well with COPD Education Program Participants Expectations Towards the Program Health in COPD
More informationDefining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist
Defining COPD Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist Defining COPD Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease
More informationONTARIO RESPIRATORY PATHOGEN BULLETIN. Assessment of Influenza Activity in Ontario
ONTARIO RESPIRATORY PATHOGEN BULLETIN Surveillance Week 44: (October 28, 2018 - November 3, 2018) This issue of the Ontario Respiratory Pathogen Bulletin provides information on the surveillance period
More informationChronic Obstructive Pulmonary Disease Guidelines and updates
Chronic Obstructive Pulmonary Disease Guidelines and updates October 20, 2018 Saratoga Springs, NY COPD (Chronic obstructive pulmonary disease) is a major cause of mortality and morbidity in the United
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationClinical Practice Guideline: Asthma
Clinical Practice Guideline: Asthma INTRODUCTION A critical aspect of the diagnosis and management of asthma is the precise and periodic measurement of lung function both before and after bronchodilator
More informationProvincial Digital QBP Order Sets Program. Champlain Lung Health Network Meeting June 20, 2017
Provincial Digital QBP Order Sets Program Champlain Lung Health Network Meeting June 20, 2017 Provincial Program Background The Ministry of Health and Long-Term Care (Ministry) is funding a provincial
More informationWhat is New in COPD: Times Are Changing! Meredith Chiasson, MD, FRCPC April 6, 2018
What is New in COPD: Times Are Changing! Meredith Chiasson, MD, FRCPC April 6, 2018 No disclosures Disclosures objectives How to diagnose & Assess severity Treatment: Pharmacologic Non-Pharmacologic Maintenance
More informationTake on Tobacco! A Guide to the new Certified Tobacco Educator Examination
Take on Tobacco! A Guide to the new Certified Tobacco Educator Examination Take on Tobacco! The Certified Tobacco Educator Designation The Certified Tobacco Educator (CTE) credential recognizes healthcare
More informationONTARIO RESPIRATORY PATHOGEN BULLETIN. Assessment of Influenza Activity in Ontario
ONTARIO RESPIRATORY PATHOGEN BULLETIN Surveillance Week 49: (December 2, 2018 - December 8, 2018) This issue of the Ontario Respiratory Pathogen Bulletin provides information on the surveillance period
More information9/22/2015 CONFLICT OF INTEREST OBJECTIVES. Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR
Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org scerreta@copdfoundation.org CONFLICT OF INTEREST
More informationUnderstanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR
Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org scerreta@copdfoundation.org CONFLICT OF INTEREST
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #51 (NQF 0091): Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
More informationOntario Novel H1N1 Influenza A Virus Epidemiologic Summary June 4, 2009 As of 8:30am, June 4, 2009
Ontario Novel H1N1 Influenza A Virus Epidemiologic Summary June 4, 29 As of 8:3am, June 4, 29 Background On April 2, 29, the Public Health Agency of Canada alerted the Ministry of Health and Long-Term
More information